Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-056379·ADIAL PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
ADIAL PHARMACEUTICALS INC
Common stock, par value $0.001 per share · CUSIP: 00688A205
Event date: 2025-06-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mitchell P. Kopin
Shares: 446,282.00 · Class: 2.8%
- Daniel B. Asher
Shares: 446,282.00 · Class: 2.8%
- Intracoastal Capital LLC
Shares: 446,282.00 · Class: 2.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-056379
- Form type
- SCHEDULE 13G
- Filer
- ADIAL PHARMACEUTICALS, INC.
- CIK
- CIK 1513525
- Filed
- Jun 23, 2025
- Reporting period
- Jun 17, 2025
- Description
- Schedule 13G beneficial ownership